ASX Share rice
Sat 19 Jun 2021 - 09:13:am (Sydney)

BXN Share Price

BIOXYNE LIMITEDBXNHousehold & Personal Products

BXN Company Information

Name:

Bioxyne Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

50 Clarence Street Sydney NSW Australia 2000

Phone:

61 2 9078 8180

MD, CEO & Director:

Mr. Nam Hoat Chua B.A., BA

CFO & Company Sec.:

Mr. Guy Adrian Robertson B.Com., C.A., B.Comm(Hons.), CA, MAICD

Company Overview:

Bioxyne Limited, a life sciences and health products company, researches, develops, manufactures, markets, and distributes consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus Fermentum PCC. The company operates in two segments, Wholesale Sales and Direct Sales segments. It also engages in developing a range of functional foods and beauty products. The company's products portfolio include BK18, a dairy based food supplement; Allura, a beauty drink for women's weight management; Mustang, a nutritional shake for men's weight management; Mymana, a colostrum and fortified milk formula for nutrition and immune support; and BEssence, an anti-ageing serum. In addition, it offers its probiotic products under the Progastrim and proTract names. The company provides its products online, as well as through retail channels in Australia, the United States, New Zealand, and Asia. Bioxyne Limited was incorporated in 1998 and is headquartered in Sydney, Australia.

BXN Share Price Information

Shares Issued:

640.15M

Market Capitalisation:

$14.72M

Revenue (TTM):

$2.18M

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.002

Profit Margin:

-0.2859

Operating Margin (TTM):

$-0.16

Return On Assets (TTM):

$-0.07

Return On Equity (TTM):

$-0.24

Quarterly Revenue Growth (YOY):

-0.104

Gross Profit(TTM):

$1.28M

Diluted Earnings Per Share (TTM):

$-0.001

BXN CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-33,662

Change To Liabilities:

$-150,664

Total Cashflow From Investing Activities:

$-33,662

Net Borrowings:

$-52,325

Net Income:

$-593,095

Total Cash From Operating Activities:

$48.25K

Depreciation:

$72.07K

Change To Inventory:

$-54,324

Change To Account Receivables:

$483.56K

Capital Expenditures:

$33.66K

BXN Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-593,095

Net Income:

$-593,095

Gross Profit:

$1.22M

Operating Income:

$-514,196

Interest Expense:

$7.03K

Total Revenue:

$2.26M

Total Operating Expenses:

$1.73M

Cost Of Revenue:

$1.04M

BXN Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$30.27K

Total Liabilities:

$726.12K

Total Stockholder Equity:

$2.56M

Other Current Liabilities:

$62.88K

Total Assets:

$3.34M

Common Stock:

$62.18M

Other Current Assets:

$236.30K

Retained Earnings:

$-59,745,101

Cash:

$1.75M

Total Current Liabilities:

$726.12K

Property - Plant & Equipment:

$170.15K

Net Tangible Assets:

$2.46M

Total Current Assets:

$3.07M

Net Receivables:

$304.43K

Short-Term Investments:

$265.14K

Inventory:

$767.94K

Accounts Payable:

$220.23K

Short-Term Investments:

$265.14

Non Current Liabilities Total:

$0

BXN Share Price History

BXN News